CIRM Funded Clinical Trials

RPESC-RPE-4W Therapy for dry Age-related Macular Degeneration

Disease Area:
Age-related macular degeneration
Investigator:
Dr. Jeffrey H Stern
Institution:
Luxa Biotechnology
CIRM Grant:
CLIN2-15282 (Pre-Active)
Award Value:
$4,009,675.00
Trial Sponsor:
Luxa Biotechnology
Trial Stage:
Phase 1/2
Trial Status:
Launching
Targeted Enrollment:
N/A

CIRM Clinical Trial Resources

Patient Stories of Hope

CIRM Alpha Stem Cell Clinics

Patient Toolbox

Video on Stem Cell Trials

Other Resources

ISSCR Patient Website

ClinicalTrials.gov